Orion OYJ (OTCMKTS:ORINY) Announces Earnings Results

Orion OYJ (OTCMKTS:ORINY) issued its quarterly earnings results on Thursday. The company reported $0.37 earnings per share (EPS) for the quarter, Zacks reports. Orion OYJ had a net margin of 26.68% and a return on equity of 47.67%.

Orion OYJ Price Performance

OTCMKTS ORINY remained flat at $37.99 during trading hours on Thursday. The business’s 50 day moving average price is $39.30 and its 200-day moving average price is $37.66. The company has a market capitalization of $10.72 billion, a P/E ratio of 18.62 and a beta of 0.10. Orion OYJ has a one year low of $25.95 and a one year high of $42.75. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.40 and a quick ratio of 1.58.

Analysts Set New Price Targets

Separately, Danske downgraded shares of Orion OYJ from a “buy” rating to a “hold” rating in a research note on Thursday, January 15th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Orion OYJ presently has a consensus rating of “Hold”.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.